Announcements Trials
Browse Landscape

Phase

Phase NA 6Phase 2 2

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Genitourinary 2Other hematologic neoplasm 1CNS 1Breast 1

Conditions

Prostatic Neoplasms 2Sedentary Behavior 1Fatigue 1

Interventions

Docetaxel 191Gemcitabine 148Prednisone 142pembrolizumab 125enzalutamide 119Abiraterone Acetate 108Nivolumab 107Cisplatin 103Magnetic Resonance Spectroscopy 100Radiotherapy 95Sunitinib 94Leuprolide 91Carboplatin 82Specimen Handling 71Androgen Antagonists 63bicalutamide 60Radiosurgery 60Paclitaxel 59Goserelin 59Ipilimumab 57Bevacizumab 57apalutamide 53Sorafenib 53acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 51Everolimus 49cabozantinib 48abiraterone 46atezolizumab 45cabazitaxel 43durvalumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Cognitive Behavioral Therapy × Genitourinary × Clear all
NCT01410942 2026-02-20

Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
175 enrolled
Genitourinary

Fatigue, Prostatic Neoplasms

NCT03421782 2026-02-17

Fatigue Interventions in Cancer (Exercise Intervention)

University of Utah

Phase 2 Completed
126 enrolled
Genitourinary

Prostatic Neoplasms, Sedentary Behavior

Data powered by HemOnc (CC BY 4.0) Colophon âš¡